Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, March 18, 2016 11:26:30 AM
bullish 0.832
## source: finance.yahoo.com
$TBIO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TBIO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TBIO/company-info
Ticker: $TBIO
OTC Market Place: Not Available
CIK code: 0001043961
Company name: Transgenomic, Inc.
Company website: http://www.transgenomic.com
Incorporated In: DE, USA
Business Description: TRANSGENOMIC is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Our offering includes systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine.
$TBIO share structure
## source: otcmarkets.com
Market Value: $9,601,827 a/o Mar 17, 2016
Shares Outstanding: 13,915,691 a/o Oct 31, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$TBIO extra dd links
Company name: Transgenomic, Inc.
Company website: http://www.transgenomic.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TBIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TBIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TBIO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TBIO/news - http://finance.yahoo.com/q/h?s=TBIO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TBIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TBIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TBIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TBIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Transgenomic%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Transgenomic%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Transgenomic%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.transgenomic.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.transgenomic.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.transgenomic.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TBIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001043961&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TBIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TBIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TBIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TBIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TBIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TBIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TBIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TBIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TBIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TBIO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TBIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TBIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TBIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TBIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TBIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TBIO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TBIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TBIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TBIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TBIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TBIO
$TBIO DD Notes ~ http://www.ddnotesmaker.com/TBIO
Recent PRPO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:20:29 PM
- Precipio Secures a short-term $500K Credit Facility • GlobeNewswire Inc. • 05/06/2024 09:00:00 PM
- Precipio Announces Year end 2023 Shareholder Update Call • GlobeNewswire Inc. • 03/25/2024 09:00:00 PM
- Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY • GlobeNewswire Inc. • 02/13/2024 03:00:00 PM
- Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer • GlobeNewswire Inc. • 02/06/2024 03:00:00 PM
- Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter • GlobeNewswire Inc. • 01/23/2024 03:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/19/2024 09:05:44 PM
- Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan • GlobeNewswire Inc. • 01/17/2024 03:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:33:26 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 10:01:11 PM
- Precipio Announces Christina Valauri joins the Board of Directors • GlobeNewswire Inc. • 01/02/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 10:00:22 PM
- Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 • GlobeNewswire Inc. • 12/14/2023 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:15:16 PM
- Precipio Announces Q3-2023 Shareholder Update Call • GlobeNewswire Inc. • 11/16/2023 10:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 08:30:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:30:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:30:25 PM
- Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022 • GlobeNewswire Inc. • 10/18/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:34:18 PM
- Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023 • GlobeNewswire Inc. • 10/03/2023 02:00:00 PM
- Precipio Continues to Sign New HemeScreen™ Customers • GlobeNewswire Inc. • 09/28/2023 01:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM